Related Articles
Triple-negative breast cancer exhibits a favorable response to neoadjuvant chemotherapy independent of the expression of topoisomerase Ⅱα
Triple-negative breast cancer types exhibit a distinct poor clinical characteristic in lymph node-negative Chinese patients
Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer
Strong impact of pathological node‑negative on long‑term overall survival of patients with triple‑negative breast cancer receiving neoadjuvant chemotherapy
Status and prognostic value of immunological biomarkers of breast cancer